186. Deputy Jack Chambers asked the Minister for Health if clarity will be provided on a clinical drug trial relating to Duchenne muscular dystrophy for which Dublin would be a trial site (details supplied); the reason the drug trial was not carried out in Dublin; if this was due to a decision by the company; if so, the reason provided for the decision not to use Dublin as a trial site; the efforts under way to have Dublin reinstated as a trial site; if his attention has been drawn to the distress caused to families of persons with the condition by the decision not to carry out this drug trial here; and if he will make a statement on the matter. [40096/19]

Summary

186. Deputy Jack Chambers asked the Minister for Health if clarity will be provided on a clinical drug trial relating to Duchenne muscular dystrophy for which Dublin would be a trial site (details supplied); the reason the drug trial was not carried out in Dublin; if this was due to a decision by the company; if so, the reason provided for the decision not to use Dublin as a trial site; the efforts under way to have Dublin reinstated as a trial site; if his attention has been drawn to the distress caused to families of persons with the condition by the decision not to carry out this drug trial here; and if he will make a statement on the matter. [40096/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Drug Trials

  xml · EN · 2 October 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.